Vertex Pharmaceuticals (VRTX) News Today $422.00 +5.04 (+1.21%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Zhang Financial LLC Boosts Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Zhang Financial LLC raised its holdings in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 14.8% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 4,631January 20 at 8:44 AM | marketbeat.comDiversify Wealth Management LLC Raises Stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Diversify Wealth Management LLC increased its position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 160.9% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 9,773 shares of thJanuary 20 at 6:22 AM | marketbeat.comJ2 Capital Management Inc Invests $270,000 in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)J2 Capital Management Inc bought a new stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 671 shares of the pharmaceutical company's stock, valued at approximatJanuary 19 at 7:33 AM | marketbeat.comInTrack Investment Management Inc Has $878,000 Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)InTrack Investment Management Inc increased its holdings in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 49.9% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 2,132 shares of the pharmaceutical cJanuary 18 at 8:28 AM | marketbeat.com3 Unstoppable Stocks to Buy in 2025January 18 at 6:40 AM | fool.comAvanza Fonder AB Takes $11.34 Million Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Avanza Fonder AB purchased a new stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 28,158 shares of the pharmaceutical company's stocJanuary 17 at 9:37 AM | marketbeat.comRDA Financial Network Trims Stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)RDA Financial Network lowered its position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 32.1% in the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 5,017 shares of the pharmaceutical company's stock after selling 2,375 sJanuary 17 at 8:50 AM | marketbeat.comVertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Purchased by First Pacific FinancialFirst Pacific Financial grew its holdings in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 76.4% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,725 shares of the pharmaceutJanuary 17 at 8:35 AM | marketbeat.comChannel Wealth LLC Invests $716,000 in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Channel Wealth LLC purchased a new stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 1,778 shares of the pharmaceutical company's stJanuary 17 at 8:17 AM | marketbeat.comEmpirical Asset Management LLC Grows Stock Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Empirical Asset Management LLC increased its stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 3,381.4% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 65,763 shares oJanuary 17 at 7:48 AM | marketbeat.comGateway Investment Advisers LLC Lowers Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Gateway Investment Advisers LLC trimmed its holdings in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 1.1% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor ownJanuary 17 at 5:35 AM | marketbeat.comVertex Pharmaceuticals (VRTX) Dips More Than Broader Market: What You Should KnowJanuary 16, 2025 | msn.comHHS Challenges Vertex Over Fertility Services Program Tied To Casgevy Gene Therapy, Says Company Is 'Grasping at Straws'January 16, 2025 | benzinga.comVertex's Pain Drug: Big Pharma's Next Major Success?Vertex Pharmaceuticals' innovative pain drug holds significant potential, positioning the company for substantial growth in the expanding market.January 16, 2025 | marketbeat.comShould You Buy Vertex Pharmaceuticals Stock Hand Over Fist Before Jan. 30?January 16, 2025 | fool.comThurston Springer Miller Herd & Titak Inc. Purchases 673 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Thurston Springer Miller Herd & Titak Inc. lifted its position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 61.4% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 1,769 shares of the pharmaceutical company's stJanuary 16, 2025 | marketbeat.comBurney Co. Has $15.21 Million Stock Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Burney Co. cut its holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 18.2% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 37,767 shares of the pharmaceutical company's stock after sellingJanuary 15, 2025 | marketbeat.comAssenagon Asset Management S.A. Boosts Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)Assenagon Asset Management S.A. boosted its holdings in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 169.4% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor ownedJanuary 15, 2025 | marketbeat.comVertex Pharmaceuticals (NASDAQ:VRTX) Earns "Outperform" Rating from William BlairJanuary 15, 2025 | americanbankingnews.comBernstein Sticks to Its Hold Rating for Vertex Pharmaceuticals (VRTX)January 14, 2025 | markets.businessinsider.comHere's How Much $100 Invested In Vertex Pharmaceuticals 10 Years Ago Would Be Worth TodayJanuary 14, 2025 | benzinga.comVertex Pharmaceuticals Sets Sight on Expanding Portfolio with Alyftrek Approval, Pain Treatment Progress, and Diabetes TrialsJanuary 14, 2025 | benzinga.comVertex Pharmaceuticals: Strong Pipeline and Strategic Growth Propel ‘Buy’ RatingJanuary 14, 2025 | markets.businessinsider.comVertex Pharmaceuticals: Strong Future Potential with Key Drug Launches and Underappreciated OpportunitiesJanuary 13, 2025 | markets.businessinsider.comVertex Pharmaceuticals' (VRTX) "Outperform" Rating Reaffirmed at William BlairWilliam Blair reissued an "outperform" rating on shares of Vertex Pharmaceuticals in a research note on Monday.January 13, 2025 | marketbeat.comPiper Sandler Sticks to Their Buy Rating for Vertex Pharmaceuticals (VRTX)January 13, 2025 | markets.businessinsider.comVertex Pharmaceuticals Incorporated (VRTX) CEO Reshma Kewalramani Hosts 43rd Annual J.P. Morgan Healthcare Conference (Transcript)January 13, 2025 | seekingalpha.comVertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Stock Holdings Boosted by Czech National BankCzech National Bank increased its position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 6.2% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 55,838 shares of the pharmaceutical cJanuary 13, 2025 | marketbeat.comMy 3 Highest-Conviction Growth Stocks to Buy in 2025January 13, 2025 | fool.comInternational Assets Investment Management LLC Lowers Stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)International Assets Investment Management LLC lowered its position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 99.8% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owJanuary 13, 2025 | marketbeat.comVertex Pharmaceuticals (NASDAQ:VRTX) Price Target Cut to $460.00 by Analysts at Wells Fargo & CompanyJanuary 13, 2025 | americanbankingnews.comVertex Pharmaceuticals Inc (VRTX) Announces Significant Program Updates Ahead of 2025January 12, 2025 | gurufocus.comVertex Pharmaceuticals Inc (VRTX) Announces Significant Program Updates Ahead of 2025January 12, 2025 | gurufocus.comVertex Pharmaceuticals Inc (VRTX) Announces Significant Program Updates Ahead of 2025January 12, 2025 | gurufocus.comVertex Provides Pipeline and Business Updates in Advance of Upcoming Investor MeetingsJanuary 12, 2025 | businesswire.comVertex Pharmaceuticals price target lowered to $456 from $476 at Morgan StanleyJanuary 10, 2025 | markets.businessinsider.comVertex Pharmaceuticals (VRTX) Stock Moves -0.62%: What You Should KnowJanuary 10, 2025 | msn.comVertex Pharmaceuticals: Hold Rating Amid Mixed Results for Suzetrigine in LSR and Optimistic Prospects in Acute PainJanuary 10, 2025 | markets.businessinsider.comWells Fargo Issues a Buy Rating on Vertex Pharmaceuticals (VRTX)January 10, 2025 | markets.businessinsider.comCCM Investment Advisers LLC Reduces Stock Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)CCM Investment Advisers LLC lessened its holdings in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 25.9% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 22,202 shares ofJanuary 10, 2025 | marketbeat.comAn Intrinsic Calculation For Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Suggests It's 42% UndervaluedJanuary 10, 2025 | finance.yahoo.comWells Fargo & Company Cuts Vertex Pharmaceuticals (NASDAQ:VRTX) Price Target to $460.00Wells Fargo & Company lowered their target price on shares of Vertex Pharmaceuticals from $555.00 to $460.00 and set an "overweight" rating on the stock in a report on Friday.January 10, 2025 | marketbeat.comVertex Pharmaceuticals Incorporated (VRTX) Slid due to Setbacks In Clinical TrialsJanuary 10, 2025 | insidermonkey.comVertex Pharmaceuticals and Zai Lab Announce Strategic Collaboration for Povetacicept in AsiaJanuary 10, 2025 | gurufocus.comZai Lab Ltd (ZLAB) Partners with Vertex Pharmaceuticals for Povetacicept Development in AsiaJanuary 10, 2025 | gurufocus.comZai Lab and Vertex Announce Strategic Agreement to Develop and Commercialize Povetacicept in Mainland China, Hong Kong SAR, Macau SAR, Taiwan region and SingaporeJanuary 10, 2025 | businesswire.comVertex and Zai Lab Announce Strategic Agreement to Develop and Commercialize Povetacicept in Mainland China, Hong Kong SAR, Macau SAR, Taiwan Region and SingaporeJanuary 10, 2025 | businesswire.comVertex Pharmaceuticals, Orna Therapeutics announce research collaborationJanuary 7, 2025 | markets.businessinsider.comVertex Grapples With Bearish Chart As Death Cross EmergesJanuary 7, 2025 | benzinga.com2 Gene-Editing Stocks Positioned for a Strong Comeback in 2025 (VRTX)Gene editing is a reality and it has potential to cure hereditary diseases in a single treatment. These 2 stocks are pioneers in the CRISPR/Cas-9 space.January 7, 2025 | marketbeat.com Get Vertex Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for VRTX and its competitors with MarketBeat's FREE daily newsletter. Email Address VRTX Media Mentions By Week VRTX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VRTX News Sentiment▼0.830.44▲Average Medical News Sentiment VRTX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VRTX Articles This Week▼2819▲VRTX Articles Average Week Get Vertex Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for VRTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Amgen News Gilead Sciences News Regeneron Pharmaceuticals News Alnylam Pharmaceuticals News Biogen News United Therapeutics News Neurocrine Biosciences News Incyte News BioMarin Pharmaceutical News Exelixis News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:VRTX) was last updated on 1/20/2025 by MarketBeat.com Staff From Our PartnersLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | SponsoredKamala’s final humiliation The investments connected to Trump's second term in ways that almost nobody outside his inner circle is aware ...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredStunning Trump Exec Order LeakedMost people have no clue this unassuming facility exists. Yet the minute Donald Trump takes office... ...Banyan Hill Publishing | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vertex Pharmaceuticals Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share Vertex Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free VRTX Stock Alerts